📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The knowns and unknowns of teprotumumab for thyroid eye disease. (2021)

First Author: Bednarczuk T

Attributed to: Plasma-cell depletion therapy for severe Graves' disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2213-8587(21)00076-0

PubMed Identifier: 33865499

Publication URI: http://europepmc.org/abstract/MED/33865499

Type: Journal Article/Review

Volume: 9

Parent Publication: The lancet. Diabetes & endocrinology

Issue: 6

ISSN: 2213-8587